Prolactin Activates ERα in the Absence of Ligand in Female Mammary Development and Carcinogenesis in Vivo

Resistance of estrogen receptor positive (ERα+) breast cancers to antiestrogens is a major factor in the mortality of this disease. Although activation of ERα in the absence of ligand is hypothesized to contribute to this resistance, the potency of this mechanism in vivo is not clear. Epidemiologic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: O'Leary, Kathleen A., Jallow, Fatou, Rugowski, Debra E., Sullivan, Ruth, Sinkevicius, Kerstin W., Greene, Geoffrey L., Schuler, Linda A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Endocrine Society 2013
Gaiak:
Cancer-Oncogenes
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3836081/
https://ncbi.nlm.nih.gov/pubmed/24064365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2013-1533
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak